Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients

References

• Zumla AI, Memish ZA. Middle east respiratory syndrome coronavirus: epidemic potential or a storm in a teacup? Eur Respir J. 2014;43(5):1243–1248. doi:10.1183/09031936.00227213
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. doi:10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• Azzi L, Baj A, Alberio T, et al. Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study. J Infect. 2020;81(3):e75–e78. doi:10.1016/j.jinf.2020.06.042
   PubMed Web of Science ®Google Scholar
• Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020;81(1):e45–e50. doi:10.1016/j.jinf.2020.04.005
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Vellingiri B, Jayaramayya K, Iyer M, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. doi:10.1016/j.scitotenv.2020.138277
   PubMed Web of Science ®Google Scholar
• Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020;53(3):425–435. doi:10.1016/j.jmii.2020.04.015
   PubMedGoogle Scholar
• Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55(6):327–331. doi:10.1097/RLI.0000000000000672
   PubMed Web of Science ®Google Scholar
• Sun Y, Koh V, Marimuthu K, et al. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020;71(15):786–792. doi:10.1093/cid/ciaa322
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Messner CB, Demichev V, Wendisch D, et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 2020;11(1):11–24 e14. doi:10.1016/j.cels.2020.05.012
   PubMed Web of Science ®Google Scholar
• Park J, Kim H, Kim SY, et al. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep. 2020;10(1):22418. doi:10.1038/s41598-020-80120-8
   PubMed Web of Science ®Google Scholar
• Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59–72 e15. doi:10.1016/j.cell.2020.05.032
   PubMed Web of Science ®Google Scholar
• Lindoso RS, Sandim V, Collino F, et al. Proteomics of cell-cell interactions in health and disease. Proteomics. 2016;16(2):328–344. doi:10.1002/pmic.201500341
   PubMed Web of Science ®Google Scholar
• Alaiya AA, Aljurf M, Shinwari Z, et al. Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients. Int J Oncol. 2016;49(3):913–933. doi:10.3892/ijo.2016.3618
   PubMed Web of Science ®Google Scholar
• Molinari N, Roche S, Peoc’h K, et al. Sample pooling and inflammation linked to the false selection of biomarkers for neurodegenerative diseases in top-down proteomics: a pilot study. Front Mol Neurosci. 2018;11:477. doi:10.3389/fnmol.2018.00477
   PubMed Web of Science ®Google Scholar
• Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020;34(2):75–80. doi:10.1016/j.tmrv.2020.02.003
   PubMed Web of Science ®Google Scholar
• Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022
   PubMed Web of Science ®Google Scholar
• Leclercq I, Batejat C, Burguiere AM, Manuguerra JC. Heat inactivation of the middle east respiratory syndrome coronavirus. Influenza Other Respir Viruses. 2014;8(5):585–586. doi:10.1111/irv.12261
   PubMed Web of Science ®Google Scholar
• Pyankov OV, Bodnev SA, Pyankova OG, Agranovski IE. Survival of aerosolized coronavirus in the ambient air. J Aerosol Sci. 2018;115:158–163. doi:10.1016/j.jaerosci.2017.09.009
   PubMed Web of Science ®Google Scholar
• Alkhayal Z, Shinwari Z, Gaafar A, Alaiya A. Proteomic profiling of the first human dental pulp mesenchymal stem/stromal cells from carbonic anhydrase II deficiency osteopetrosis patients. Int J Mol Sci. 2020;22(1):380. doi:10.3390/ijms22010380
   PubMed Web of Science ®Google Scholar
• Colak D, Alaiya AA, Kaya N, et al. Integrated left ventricular global transcriptome and proteome profiling in human end-stage dilated cardiomyopathy. PLoS One. 2016;11(10):e0162669. doi:10.1371/journal.pone.0162669
   PubMed Web of Science ®Google Scholar
• Al-Saud H, Al-Romaih K, Bakheet R, et al. Automated SARS-COV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing. Ann Saudi Med. 2020;40(5):373–381. doi:10.5144/0256-4947.2020.373
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
   PubMed Web of Science ®Google Scholar
• Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222. doi:10.1186/s12985-015-0439-5
   PubMed Web of Science ®Google Scholar
• Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest. 2006;116(3):607–614. doi:10.1172/JCI27883
   PubMed Web of Science ®Google Scholar
• Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11):1045–1056. doi:10.1631/jzus.2005.B1045
   PubMedGoogle Scholar
• Gruys E, Toussaint MJ, Upragarin N, et al. Acute phase reactants, challenge in the near future of animal production and veterinary medicine. J Zhejiang Univ Sci B. 2005;6(10):941–947. doi:10.1631/jzus.2005.B0941
   PubMedGoogle Scholar
• Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:6515. doi:10.1126/science.abd4570
   Web of Science ®Google Scholar
• Matsubara K, Higaki T, Matsubara Y, Nawa A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci. 2015;16(3):4600–4614. doi:10.3390/ijms16034600
   PubMed Web of Science ®Google Scholar
• Soy M, Keser G, Atagunduz P, Tabak F, Atagunduz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020;39(7):2085–2094. doi:10.1007/s10067-020-05190-5
   PubMed Web of Science ®Google Scholar
• Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469–472. doi:10.1038/s41586-020-2332-7
   PubMed Web of Science ®Google Scholar
• Shu T, Ning W, Wu D, et al. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. 2020;53(5):1108–1122 e1105. doi:10.1016/j.immuni.2020.10.008
   PubMed Web of Science ®Google Scholar